FR2434622A1 - Solutions d'acides amines destinees a l'alimentation de patients atteints de cancer - Google Patents

Solutions d'acides amines destinees a l'alimentation de patients atteints de cancer

Info

Publication number
FR2434622A1
FR2434622A1 FR7921975A FR7921975A FR2434622A1 FR 2434622 A1 FR2434622 A1 FR 2434622A1 FR 7921975 A FR7921975 A FR 7921975A FR 7921975 A FR7921975 A FR 7921975A FR 2434622 A1 FR2434622 A1 FR 2434622A1
Authority
FR
France
Prior art keywords
cancer patients
feeding
amino acid
acid solutions
solutions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7921975A
Other languages
English (en)
French (fr)
Other versions
FR2434622B1 (de
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of FR2434622A1 publication Critical patent/FR2434622A1/fr
Application granted granted Critical
Publication of FR2434622B1 publication Critical patent/FR2434622B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
FR7921975A 1978-09-04 1979-09-03 Solutions d'acides amines destinees a l'alimentation de patients atteints de cancer Granted FR2434622A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10874978A JPS5535049A (en) 1978-09-04 1978-09-04 Amino acid transfusion for cancerous patient

Publications (2)

Publication Number Publication Date
FR2434622A1 true FR2434622A1 (fr) 1980-03-28
FR2434622B1 FR2434622B1 (de) 1983-04-15

Family

ID=14492527

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7921975A Granted FR2434622A1 (fr) 1978-09-04 1979-09-03 Solutions d'acides amines destinees a l'alimentation de patients atteints de cancer

Country Status (10)

Country Link
JP (1) JPS5535049A (de)
AU (1) AU526207B2 (de)
CA (1) CA1134275A (de)
CH (1) CH642541A5 (de)
DE (1) DE2935709C2 (de)
FR (1) FR2434622A1 (de)
GB (1) GB2029220B (de)
IT (1) IT1194844B (de)
NL (1) NL190266C (de)
SE (1) SE448679B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2591893A1 (fr) * 1985-12-19 1987-06-26 Centre Nat Rech Scient Compositions nutritionnelles carencees en methionine destinees a inhiber le developpement et la dissemination des tumeurs malignes chez les mammiferes

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0076841A4 (de) * 1981-04-17 1984-01-16 American Hospital Supply Corp Verbesserte lösung für parenterale nährung.
FR2508797B1 (fr) * 1981-07-03 1986-03-14 Charles Chany Medicament comprenant le produit de la reaction d'un acide carboxylique en c1 a c6 sur un amino-acide basique
DE3329253A1 (de) * 1983-08-12 1985-02-21 Milupa Ag, 6382 Friedrichsdorf Verwendung eines aminosaeuregemisches zur bekaempfung insbesondere von lymphadenomen
HU191598B (en) * 1984-03-20 1987-03-30 Egyt Gyogyszervegyeszeti Gyar Method for the preparation of injection solution suitable preferably against cathosis
DE3440090A1 (de) * 1984-11-02 1986-05-07 Novo-Med AG, Appenzell Aminosaeureloesungen enthaltendes arzneimittel zur therapie von krebserkrankungen und verfahren zu seiner herstellung
IL77629A (en) * 1985-01-22 1989-07-31 Abbott Lab High fat,low carbohydrate enteral nutritional for mula
US5162373A (en) * 1986-01-17 1992-11-10 Board Of Regents, The University Of Texas System Methods and improved formulations for the determination and treatment of malignant disease in patients
US5189025A (en) * 1988-12-09 1993-02-23 Board Of Regenets, The University Of Texas System Methods for the treatment of malignant disease in patients using citrulline containing amino acid solutions
GB8917660D0 (en) * 1989-08-02 1989-09-20 Rana Ashok S J Prophylaxis of transurethral resection reactions
EP0560989B1 (de) * 1991-10-07 1999-09-01 Otsuka Pharmaceutical Factory, Inc. Enterale zubereitungen zur krebstherapie
US5658895A (en) * 1991-10-07 1997-08-19 Otsuka Pharmaceutical Factory, Inc. Anticancer enteral feeding composition
DE4228897A1 (de) * 1992-08-29 1994-03-03 Wella Ag Mittel zur Festigung der Haare auf der Basis von Lignin oder Ligninderivaten sowie Dihydroxypropyllignin
DK0668933T3 (da) * 1992-11-19 2003-02-10 Anticancer Inc Anvendelse af methioninase som antitumormiddel i antimethioninkemoterapi
HU213677B (en) * 1993-11-09 1997-12-29 Immunal Kft Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them
EP0921794A1 (de) * 1996-07-30 1999-06-16 Novartis Nutrition AG Aminosäure enthaltende zusammensetzung und dessen verwendung zur behandlung von tumorwachstum und metastasen
EP1068868A3 (de) * 1997-07-08 2001-01-31 Rath, Matthias, Dr. med. Synergistischer Zusammensetzung, der Ascorbat und Lysin für Zustände enthält zur Behandlung extrazellularer Matrixdegeneration
PT1163904E (pt) * 2000-06-16 2006-07-31 Rath Matthias Composicao para a prevencao de doencas do musculo liso, compreendendo ascorbato, arginina e magnesio
DE60028376T2 (de) * 2000-10-09 2007-06-06 Rath, Matthias, Dr. Therapeutische Kombination des Ascorbats mit Lysin und Arginin für Verhinderung und Behandlung des Krebses
CH694549A5 (de) 2001-01-16 2005-03-31 Dr Matthias Rath Verwendung einer synergistischen Zusammensetzung, die Ascorbat und Lysin für Zustände enthält zur Behandlung extrazellularer Matrixdegeration.
US6686340B2 (en) 2001-06-19 2004-02-03 Matthias Rath Composition and method for prevention and treatment of health conditions caused by constriction of smooth muscle cells
SG106614A1 (en) * 2001-06-21 2004-10-29 Matthias Rath Dr Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body
JPWO2003030890A1 (ja) * 2001-10-05 2005-02-10 哲朗 浅尾 免疫系活性化剤
US20030105104A1 (en) * 2001-11-27 2003-06-05 Burzynski Stanislaw R. Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
US20050053664A1 (en) 2003-09-08 2005-03-10 Eliezer Zomer Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
EP1734819A1 (de) * 2004-03-19 2006-12-27 Pro-Pharmaceuticals, Inc. Zusammensetzungen und verfahren für das targeting von metastasierenden tumoren mit hilfe von mehrwertigen ligandgebundenen kohlenhydratpolymeren
WO2007016952A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risk of alcohol induced esophagenal and oropharyngolaryngeal cancer
US8580750B2 (en) * 2005-07-29 2013-11-12 Tima Foundation Composition for moderating alcohol metabolism and for reducing the risk of alcohol induced diseases
WO2007016950A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risk of alcohol induced neurodegenerative disease
WO2007016951A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risc of alcohol induced pancreatic cancer
WO2007016949A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risc of alcohol induced neuropathy
WO2007016953A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing alcohol induced liver cancer risk
WO2007016954A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing drug or alcohol induced breast cancer risk
EP2156188B1 (de) 2007-03-28 2021-05-05 University of Southern California Induktion differentieller stressresistenz und verwendungen davon
US8865646B2 (en) 2007-03-28 2014-10-21 University Of South California Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
CA3045883C (en) * 2008-04-24 2022-06-28 University Of Southern California Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
EP2676664B1 (de) * 2011-02-17 2017-06-21 EA Pharma Co., Ltd. Verstärker der antitumorwirkung eines chemotherapeutischen mittels
JP2016117702A (ja) * 2014-12-22 2016-06-30 武輝 山田 ガン細胞の死滅法
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
IL296055A (en) 2017-08-14 2022-10-01 Axcella Health Inc Amino acid compounds for the treatment of liver disease
CN112839643A (zh) 2018-06-20 2021-05-25 胺细拉健康公司 用于治疗肌肉中脂肪浸润的组合物及方法
IT202000000454A1 (it) * 2020-01-13 2021-07-13 Professional Dietetics Spa Composizioni comprendenti amino acidi per la prevenzione e il trattamento del cancro

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2008137A1 (de) * 1968-05-09 1970-01-16 Astra Ab
DE2013026A1 (en) * 1970-03-19 1971-10-07 Wagner, Karl Heinz, Dr med habil Prof, 63O0Giessen Amino acid compsn against liver diseases
FR2316933A1 (fr) * 1975-07-07 1977-02-04 Fresenius Chem Pharm Ind Melanges de l-aminoacides et leur utilisation therapeutique pour le traitement d'insuffisances hepatiques et renales.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU423304A3 (de) * 1970-03-10 1974-04-05 Тейзо Хигаси, Дзинносуке Лбе, Теруо Таке, Сусуми Ватанабе , Масару Отани
DE2531204A1 (de) * 1975-07-12 1977-01-13 Fresenius Chem Pharm Ind L-aminosaeuregemische fuer parenterale oder orale anwendung

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2008137A1 (de) * 1968-05-09 1970-01-16 Astra Ab
DE2013026A1 (en) * 1970-03-19 1971-10-07 Wagner, Karl Heinz, Dr med habil Prof, 63O0Giessen Amino acid compsn against liver diseases
FR2316933A1 (fr) * 1975-07-07 1977-02-04 Fresenius Chem Pharm Ind Melanges de l-aminoacides et leur utilisation therapeutique pour le traitement d'insuffisances hepatiques et renales.

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CA1959 *
CA1970 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2591893A1 (fr) * 1985-12-19 1987-06-26 Centre Nat Rech Scient Compositions nutritionnelles carencees en methionine destinees a inhiber le developpement et la dissemination des tumeurs malignes chez les mammiferes
WO1987003810A1 (fr) * 1985-12-19 1987-07-02 Centre National De La Recherche Scientifique (Cnrs Compositions nutritionnelles carencees en methionine et supplementee en homocysteine
EP0232652A1 (de) * 1985-12-19 1987-08-19 Centre National De La Recherche Scientifique (Cnrs) Methioninmangelnde Nahrungszusammensetzungen mit ergänzendem Homocysteingehalt

Also Published As

Publication number Publication date
SE7907316L (sv) 1980-03-05
JPS6154007B2 (de) 1986-11-20
FR2434622B1 (de) 1983-04-15
NL190266B (nl) 1993-08-02
AU526207B2 (en) 1982-12-23
GB2029220A (en) 1980-03-19
AU5036879A (en) 1980-03-13
NL190266C (nl) 1994-01-03
CH642541A5 (de) 1984-04-30
NL7906620A (nl) 1980-03-06
GB2029220B (en) 1983-03-30
CA1134275A (en) 1982-10-26
SE448679B (sv) 1987-03-16
JPS5535049A (en) 1980-03-11
IT1194844B (it) 1988-09-28
DE2935709A1 (de) 1980-03-13
IT7905216A0 (it) 1979-09-03
DE2935709C2 (de) 1986-02-06

Similar Documents

Publication Publication Date Title
FR2434622A1 (fr) Solutions d'acides amines destinees a l'alimentation de patients atteints de cancer
ATE213389T1 (de) Antemortem futterzusatz für lebendes vieh
BE1002296A5 (fr) Derives peptidiques.
BR9104997A (pt) Complexos ligados em ponte a hidrogenio,processo para sua preparacao farmaceutica
KR890701545A (ko) 건선치료를 위한 제약학적 조성물
GR852541B (de)
KR930002373A (ko) 헥사펩티드
ATE3416T1 (de) Pharmakologisch aktive peptide und diese enthaltende arzneimittel.
ES2072244T1 (es) Compuestos y productos de reaccion de amadori, procedimiento para su fabricacion y uso de los mismos.
EP0264953A3 (en) Amino acid preparations containing n,n'-bis-l-amino acid-l-cystin peptides for oral and parenteral use
IT1250636B (it) Sale del diclofenac, metodo di preparazione e composizioni farmaceutiche che lo contengono.
Gambert et al. Thyroid hormone regulation of central nervous system (CNS) beta-endorphin and ACTH
IL88726A0 (en) Dihydrothienobenzodiazepinone derivatives,pharmaceutical compositions containing the same and processes for the preparation thereof
KR890017363A (ko) 스트로빌루린 유도체, 이들의 제법 및 용도
ATE92078T1 (de) Pharmakologisch aktive peptide.
JPS5668374A (en) Food composition for hepatic insufficiency
CA2099529A1 (en) Antemortem nutrient supplement for livestock
KR890000399A (ko) (e)-2-(p-플루오로펜에틸)-3-플루오로알릴아민
ATE70454T1 (de) Vincristin enthaltendes produkt.
KAPLAY et al. Regulation of tRNA methylase by thyroxine in rat liver
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
GB955683A (en) Pharmaceutical cobalamin compositions
RU92001485A (ru) Лекарственное средство для парентерального питания и дезинтоксикации
AU542310B2 (en) Glicentin related purified peptide having 30 amino acids
KR830000896A (ko) 암환자용 아미노산 수액제